Analysis of the Anticancer Drug List between the National Essential Medicines List (2018) and the WHO Model List of Essential Medicines (2017)

YAN Jia-qing, LIU Min, ZHANG Yuan, MA Ying-lin, LE Kai-di, SHEN Xin, CAO Xiu-ping, LI Guo-hui

Chinese Pharmaceutical Journal ›› 2019, Vol. 54 ›› Issue (22) : 1901-1906.

PDF(1189 KB)
PDF(1189 KB)
Chinese Pharmaceutical Journal ›› 2019, Vol. 54 ›› Issue (22) : 1901-1906. DOI: 10.11669/cpj.2019.22.016

Analysis of the Anticancer Drug List between the National Essential Medicines List (2018) and the WHO Model List of Essential Medicines (2017)

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 54(22): 1901-1906 https://doi.org/10.11669/cpj.2019.22.016

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1189 KB)

Accesses

Citation

Detail

Sections
Recommended

/